Status: current, Defined. Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3741027012 | Lapatinib only product in oral dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3741028019 | Product containing only lapatinib in oral dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Lapatinib only product in oral dose form | Is a | Lapatinib-containing product in oral dose form | true | Inferred relationship | Some | ||
| Lapatinib only product in oral dose form | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
| Lapatinib only product in oral dose form | Is a | Lapatinib only product | true | Inferred relationship | Some | ||
| Lapatinib only product in oral dose form | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Lapatinib only product in oral dose form | Has active ingredient | Lapatinib | true | Inferred relationship | Some | 1 | |
| Lapatinib only product in oral dose form | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Lapatinib ditosylate 250 mg oral tablet | Is a | False | Lapatinib only product in oral dose form | Inferred relationship | Some | |
| Lapatinib (as lapatinib ditosylate) 250 mg oral tablet | Is a | True | Lapatinib only product in oral dose form | Inferred relationship | Some |
Reference Sets
Description inactivation indicator reference set
FHIR